The brain tumor therapeutics market will register a CAGR of almost 12% by 2023

[In The News]

NEW YORK, June 12, 2019 /PRNewswire/ -- About this market The rising prevalence of brain cancer is one of the key factors that will trigger the growth of the market. Most brain tumors are identified only in the late stages. The delay in diagnosis leads to the tumor becoming malignant....

View the full article